Latest Research in CAR-T cell therapy research
34 research papers · 2026 median publication year
Top Research Topics in CAR-T cell therapy research
- Multiple Myeloma Research and Treatments — 10 papers
- CAR-T cell therapy research — 6 papers
- Chronic Lymphocytic Leukemia Research — 3 papers
- Extracellular vesicles in disease — 2 papers
- Inflammatory Biomarkers in Disease Prognosis — 2 papers
- Neutropenia and Cancer Infections — 1 papers
- Pituitary Gland Disorders and Treatments — 1 papers
- Axon Guidance and Neuronal Signaling — 1 papers
- Bone health and treatments — 1 papers
- COVID-19 and healthcare impacts — 1 papers
Highest-Cited Papers
- Hyperdiploid multiple myeloma: A heterogeneous entity requiring refined risk stratification—Insights from chromosome count and cytogenetic abnormalities
- The EF1α promoter of cilta-cel drives a highly effective GZMK+ transcriptional program
- Mapping the scientific research on mesenchymal stromal cells and multiple myeloma: a bibliometric analysis
- Dual-component CAR T cell therapy: targeting BCMA with convertible CAR and MicAbodies
- Current and new approaches to the treatment landscape for adults with Waldenström macroglobulinemia
- Circulating tumor plasma cells quantification in newly diagnosed transplant ineligible real world multiple myeloma patients: Comparison of single‐platform flow cytometry versus next generation flow
- Bone marrow miRNA signatures differentiate Waldenström macroglobulinemia from multiple myeloma and reflect disease‑specific regulatory programs
- The relationship between inflammation and multiple myeloma: insights into alterations and prognostic value
- Prognostic value of a combined systemic immune-inflammation index and prognostic nutritional index score for risk stratification in newly diagnosed multiple myeloma: a retrospective cohort study
- Independent prognostic value of the lymphocyte-to-monocyte ratio in multiple myeloma patients after adjustment for the R-ISS and the second R-ISS
- Changes in C-Reactive Protein Forecast Infection Risk Following Treatment with Chimeric Antigen Receptor T Cells
- PTTG1-driven self-amplifying loop with SP1 and ENO1 promotes IRF4-mediated myeloma progression and bone destruction
- Machine Learning‐Derived Immune Gene Signature Predicts Prognosis and Therapeutic Vulnerabilities in Multiple Myeloma
- Inflammatory bone marrow microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma
- Dynamic Prediction of Survival Outcomes in Multiple Myeloma
- Bioinformatics analysis and experimental verification of the multiple myeloma microenvironment and treatment response prediction on the basis of the ecDNA-associated gene signature
- Independent prognostic value of semaphorin-4D, interleukin-1β and complement activation in newly diagnosed multiple myeloma patients
- GPRC5D CAR-T: a new path beyond BCMA
- CXXC1-dependent IRF4 activity promotes myeloma cell fitness and sustains lenalidomide resistance
- Machine learning-based cuproptosis prognostic signature identifies LDHA as a critical regulator of progression in multiple myeloma